IRIS Accounts Production v23.2.0.158 09841953 director 1.11.21 31.10.22 31.10.22 false true false false true false ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098419532021-10-31098419532022-10-31098419532021-11-012022-10-31098419532020-10-31098419532020-11-012021-10-31098419532021-10-3109841953ns10:Originalns15:EnglandWales2021-11-012022-10-3109841953ns14:PoundSterlingns10:Original2021-11-012022-10-3109841953ns10:Originalns10:Director12021-11-012022-10-3109841953ns10:Original2021-11-012022-10-3109841953ns10:Original2022-10-3109841953ns10:Originalns10:PrivateLimitedCompanyLtd2021-11-012022-10-3109841953ns10:Originalns10:SmallEntities2021-11-012022-10-3109841953ns10:Originalns10:AuditExempt-NoAccountantsReport2021-11-012022-10-3109841953ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-11-012022-10-3109841953ns10:SmallCompaniesRegimeForAccountsns10:Original2021-11-012022-10-3109841953ns10:Originalns10:FullAccounts2021-11-012022-10-3109841953ns10:Originalns10:OrdinaryShareClass12021-11-012022-10-3109841953ns10:Originalns10:RegisteredOffice2021-11-012022-10-3109841953ns10:Original2021-10-3109841953ns10:Originalns5:CurrentFinancialInstruments2022-10-3109841953ns10:Originalns5:CurrentFinancialInstruments2021-10-3109841953ns5:ShareCapitalns10:Original2022-10-3109841953ns5:ShareCapitalns10:Original2021-10-3109841953ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3109841953ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-10-3109841953ns10:Originalns5:ComputerEquipment2021-11-012022-10-3109841953ns10:Original2020-11-012021-10-3109841953ns10:Originalns5:ComputerEquipment2021-10-3109841953ns10:Originalns5:ComputerEquipment2022-10-3109841953ns10:Originalns5:ComputerEquipment2021-10-3109841953ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3109841953ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-10-3109841953ns10:Originalns10:OrdinaryShareClass12022-10-31
REGISTERED NUMBER: 09841953 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2022

for

Surgedoc Ltd

Surgedoc Ltd (Registered number: 09841953)






Contents of the Financial Statements
for the Year Ended 31 October 2022




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Surgedoc Ltd

Company Information
for the Year Ended 31 October 2022







DIRECTOR: H N S Al-Musawy





REGISTERED OFFICE: 28 Mulgrave Road
Harrow
United Kingdom
HA1 3UG





REGISTERED NUMBER: 09841953 (England and Wales)





ACCOUNTANTS: Preston Accountants Limited
Chartered Certified Accountants
1 Carlton Parade
Preston Road
Wembley
Middlesex
HA9 8NE

Surgedoc Ltd (Registered number: 09841953)

Statement of Financial Position
31 October 2022

31.10.22 31.10.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,855 894

CURRENT ASSETS
Debtors 5 9,075 11,080
Cash at bank 16,962 33,975
26,037 45,055
CREDITORS
Amounts falling due within one year 6 8,183 4,297
NET CURRENT ASSETS 17,854 40,758
TOTAL ASSETS LESS CURRENT
LIABILITIES

21,709

41,652

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 21,609 41,552
SHAREHOLDERS' FUNDS 21,709 41,652

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 October 2023 and were signed by:




H N S Al-Musawy - Director


Surgedoc Ltd (Registered number: 09841953)

Notes to the Financial Statements
for the Year Ended 31 October 2022

1. STATUTORY INFORMATION

Surgedoc Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2021 - 2 ) .

Surgedoc Ltd (Registered number: 09841953)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 November 2021 1,747
Additions 3,925
At 31 October 2022 5,672
DEPRECIATION
At 1 November 2021 853
Charge for year 964
At 31 October 2022 1,817
NET BOOK VALUE
At 31 October 2022 3,855
At 31 October 2021 894

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Directors' loan accounts 9,075 4,891
Tax - 6,189
9,075 11,080

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Social security and other taxes - 871
Net wages payable 5,333 -
Accrued expenses 2,850 3,426
8,183 4,297

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.22 31.10.21
value: £    £   
100 ordinary Shares 1 100 100

8. COMPENSATION FEES

The company had to pay its share of compensation to a patient in respect of special and provisional damages and disbursements.The total amount of payout is £44,500.